Level C· Early human research exploring benefitsProspective StudyEurope PMC

Restoration of Hydrogen Sulfide Production in Diabetic Mice Improves Reparative Function of Bone Marrow Cells

Cheng Z., Garikipati VN., Nickoloff E., Wang C., Polhemus DJ., Zhou J.

Prospective Study on Cardiovascular Disease, Peripheral Artery Disease, published in Circulation (2016) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Circulation (2016)
Reported sample size
—
Source database
Europe PMC
PMID
27660293
PMCID
PMC5101140
DOI
10.1161/circulationaha.116.022967
Citations
46

Abstract (original English)

Background Bone marrow cell (BMC)-based treatment for critical limb ischemia in diabetic patients yielded a modest therapeutic effect resulting from cell dysfunction. Therefore, approaches that improve diabetic stem/progenitor cell functions may provide therapeutic benefits. Here, we tested the hypothesis that restoration of hydrogen sulfide (H 2 S) production in diabetic BMCs improves their reparative capacities. Methods Mouse BMCs were isolated by density-gradient centrifugation. Unilateral hind limb ischemia was conducted in 12- to 14-week-old db/+ and db/db mice by ligation of the left femoral artery. The H 2 S level was measured by either gas chromatography or staining with florescent dye sulfidefluor 7 AM. Results Both H 2 S production and cystathionine γ-lyase (CSE), an H 2 S enzyme, levels were significantly decreased in BMCs from diabetic db/db mice. Administration of H 2 S donor diallyl trisulfide (DATS) or overexpression of CSE restored H 2 S production and enhanced cell survival and migratory capacity in high glucose (HG)-treated BMCs. Immediately after hind limb ischemia surgery, the db/+ and db/db mice were administered DATS orally and/or given a local intramuscular injection of green fluorescent protein-labeled BMCs or red fluorescent protein-CSE-overexpressing BMCs (CSE-BMCs). Mice with hind limb ischemia were divided into 6 groups: db/+, db/db, db/db+BMCs, db/d

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Bone Marrow CellsHindlimbAnimalsHumansMiceDiabetic AngiopathiesIschemiaDiabetes Mellitus, ExperimentalHydrogen SulfideBone Marrow Transplantation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research